Adductor Canal Block Versus Periarticular Bupivicaine Injection in Total Knee Arthroplasty
Completed · Phase 4
Conditions studied: Osteoarthritis
In brief
The objective of the study is to compare the efficacy of adductor canal blocks versus periarticular bupivacaine injections for pain management in total knee arthroplasty. This randomized clinical trial will compare outcomes between adductor canal blocks, periarticular bupivacaine injections, and periarticular liposomal bupivacaine injections. Results from this study will help determine the most appropriate perioperative pain management strategy for patients undergoing a total knee arthroplasty.
Key facts
- Study ID
- NCT02777749
- Run by
- Columbia University
- People needed
- 155
- Starts
- 2016-07-19
- Expected to finish
- 2017-11-01
- Last updated by the study team
- 2019-03-20
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing an unilateral primary total knee arthroplasty under the care of the two senior arthroplasty surgeons.
You may not qualify if…
- Allergy to bupivicaine or liposomal bupivicaine.
Where it is running
- Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.